| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Qian LinLin | Chief Financial Officer, Director, 10%+ Owner | 701 S. COLORADO AVE,, SUITE 1, STUART | /s/ LinLin Qian | 2025-09-26 | 0001849454 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HIT | Class A Common Stock | Award | $0 | +80K | +0.99% | $0.00 | 8.13M | Sep 24, 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative. |
| F2 | Includes 130,495 shares of restricted stock and 7,998,060 shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock. |